An in-vitro investigation of drug availability from lipophilic solutions.
An in-vitro model, previously described, has been modified and used to investigate the effects of volume and concentration on the release of 4-hydroxybenzoic acid from 1-octanol and isopropyl myristate. Solutions encapsulated in soft gelatin shells have also been examined. The quantity of solute released can be increased by reducing the volume of solvent used to prepare the solution, or by increasing the concentration of the solution. The release profile from an encapsulated solution is different from that obtained with the same, unencapsulated solution. The difference is attributed to absorption of the solute by the capsule shell.
D020003:1-Octanol; D002214:Capsules; D006863:Hydrogen-Ion Concentration; D062385:Hydroxybenzoates; D008055:Lipids; D009226:Myristates; D000442:Octanols; D010226:Parabens; D010539:Permeability; D012995:Solubility; D012996:Solutions
D002214:Capsules; D062385:Hydroxybenzoates; D008055:Lipids; D009226:Myristates; D000442:Octanols; D010226:Parabens; D012996:Solutions; C008205:isopropyl myristate; C038193:4-hydroxybenzoic acid; D020003:1-Octanol